IP Library Granted Patent US 9,295,664
Granted Patent B2
US 9,295,664 · App. 14/124,582 · Granted Mar 29, 2016

Methods for lowering blood glucose

Inventors: Christopher M. Adams (Iowa City, IA); Steven D. Kunkel (Iowa City, IA); Michael Welsh (Riverside, IA)
Assignee: UNIVERSITY OF IOWA RESEARCH FOUNDATION
A61K31/353A61K31/215A61K31/352A61K31/36A61K31/382A61K31/404A61K31/407A61K31/4164A61K31/4166A61K31/435A61K31/436A61K31/437A61K31/438A61K31/4355A61K31/4365A61K31/4375A61K31/473A61K31/4706A61K31/56A61K31/565A61K31/58C12Q1/6809G01N33/5023C12Q2600/136G01N2800/10G01N2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,295,664
App. No.
14/124,582
Granted
Mar 29, 2016
Kind
B2
Abstract

In one aspect, the invention relates to methods for treating muscle atrophy by providing to an animal in need thereof an effective amount of a compound. The compound can modulate the expression levels of multiple mRNA of a muscle atrophy signature. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claims (5)

1. A method of lowering blood glucose in an animal comprising administering to the animal a composition comprising from 25 to 500 mg of ursolic acid, and a compound having a structure represented by a formula:

wherein each ----- represents a covalent bond selected from a single or double bond;

wherein each of R 21a , R 21b , R 21c , R 21d , R 21e , R 22 , R 23a , R 23b , R 23c and R 23d in said formula is chosen independently from H and OH or a stereoisomer, tautomer, solvate, or pharmaceutically acceptable salt thereof;

thereby lowering the blood glucose in the animal.

2. A method of lowering blood glucose in an animal comprising administering to the animal a composition comprising from 25 to 500 mg of ursolic acid, and a compound of formula:

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE FIRST ASSIGNEE AND ADDRESS OF THE SECOND ASSIGNEE PREVIOUSLY RECORDED ON REEL 039156 FRAME 0224. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Recorded Nov 8, 2018
From: ADAMS, CHRISTOPHER M.; KUNKEL, STEVEN D.
To: UNIVERSITY OF IOWA RESEARCH FOUNDATION; THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 048368/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2016
From: UNIVERSITY OF IOWA RESEARCH FOUNDATION
To: ADAMS, CHRISTOPHER M; KUNKEL, STEVEN D
Reel/Frame 039156/0208 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2016
From: ADAMS, CHRISTOPHER M; KUNKEL, STEVEN D
To: UNIVERSITY OF IOWA RESEARCH FOUNDATION; THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 039156/0224 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2014
From: ADAMS, CHRISTOPHER M.; KUNKEL, STEVEN D.; WELSH, MICHAEL
To: UNIVERSITY OF IOWA RESEARCH FOUNDATION
Reel/Frame 032549/0259 →
CONFIRMATORY LICENSE Recorded Jan 17, 2014
From: UNIVERSITY OF IOWA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032086/0762 →
Continuity (2)
Provisional Application 61493969 · Jun 6, 2011
Related Publication 20140228333A1 · Aug 14, 2014